The investor presentation “MagSense® Technology: Early Detection of Cancer Through Targeted Imaging” has been announced and is available for download here.
Download the non-deal roadshow presentation MagSense Technology.
Quarterly Activity Report – Quarter ending 31 December 2023
January 31, 2024
Highlights: Announced positive results from IBI10103 Phase I Study demonstrating safety and clinical feasibility of molecular MRI with MagSense® HER2 Imaging Agent Presented new animal